Published guidance, NICE advice and quality standards | Guidance

Showing 221 to 230 of 797

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Roxadustat for treating symptomatic anaemia in chronic kidney disease	TA807	13 July 2022	13 July 2022
Fenfluramine for treating seizures associated with Dravet syndrome	TA808	8 July 2022	8 July 2022
Teduglutide for treating short bowel syndrome	TA804	30 June 2022	30 June 2022
Faricimab for treating diabetic macular oedema	TA799	29 June 2022	29 June 2022
Faricimab for treating wet age-related macular degeneration	TA800	29 June 2022	29 June 2022
Pembrolizumab plus chemotherapy for untreated, triple-negative, locally recurrent unresectable or metastatic breast cancer	TA801	29 June 2022	29 June 2022
Cemiplimab for treating advanced cutaneous squamous cell carcinoma	TA802	29 June 2022	29 June 2022
Durvalumab for maintenance treatment of unresectable non-small-cell lung cancer after platinum-based chemoradiation	TA798	22 June 2022	22 June 2022
Venetoclax for treating chronic lymphocytic leukaemia	TA796	15 June 2022	15 June 2022
Enfortumab vedotin for previously treated locally advanced or metastatic urothelial cancer (terminated appraisal)	TA797	15 June 2022	15 June 2022